Hemoptysis After CardioMEMS Implantation: Case Report and Review
View/ Open
Issue Date
2018-03-31Author
Rali, Aniket S.
Shah, Zubair
Sauer, Andrew J.
Gupta, Kamal
Publisher
International Scientific Information, Inc.
Type
Article
Article Version
Scholarly/refereed, publisher version
Rights
This work is licensed under Creative Common Attribution-
NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Metadata
Show full item recordAbstract
The CardioMEMS heart failure system is a small sensor that is placed in a branch pulmonary artery for ambulatory
monitoring of pulmonary artery pressures. CardioMEMS has been approved for use in the United States
in patients with New York Heart Association (NYHA) class III heart failure and frequent hospitalizations. In this
report we describe a patient who had hemoptysis after CardioMEMS implantation. Further, we discuss possible
etiologies for the occurrence of hemoptysis and suggest strategies to minimize this risk.
Case Report: The patient was a 79-year-old female with NYHA class III heart failure with non-ischemic cardiomyopathy (LVEF
40%) and chronic atrial fibrillation who was referred for CardioMEMS implantation. The procedure was completed
uneventfully. The patient was transferred out of the procedure suite to the recovery area where she developed
a slight cough approximately 20 minutes after the implantation. Within a few coughs the patient started
having hemoptysis. She was transferred to the cardiac intensive care unit for observation. She was kept off
warfarin and aspirin and her hemoptysis resolved 3 days later. While the exact etiology of hemoptysis in this
patient was unclear, we felt that it may have been precipitated by a minor wire-induced distal branch pulmonary
artery injury.
Conclusions: Our report discusses hemoptysis as a potential life-threatening complication of CardioMEMS sensor implantation
while suggesting possible etiologies and avoidance strategies. As the utilization of this technology expands
in the years to come, a more comprehensive national registry for surveillance of device related complications
will be crucial.
Description
A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.
Collections
Citation
Rali A.S. et al.: Hemoptysis post CardioMEMS implantation © Am J Case Rep, 2018; 19: 382-385 www.doi.org/10.12659/AJCR.908508
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.